Alpha 1 Proteinase Inhibitor (Ageronix)

N/A

Report date: 2025/01/26 18:28:29

Base Information

Drug NameAlpha 1 Proteinase Inhibitor (Ageronix)
Drug Alias Namehuman alpha 1 anti-trypsin (Ageronix)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionSerine protease inhibitorsAlpha-1-antiproteinase stimulants
TargetsSerine proteaseAlpha-1-antiproteinase
Therapy Area/IndicationsCharcot-Marie-Tooth Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAgeronix SA
China Registration ClassN/A

Develop Information

Active CompaniesAgeronix SA
Inactive CompaniesN/A
Active IndicationsCharcot-Marie-Tooth Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A